台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股▼2.18%
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-中國信託-松江 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/249095100105110115120125May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

中國信託-松江 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/2500.0027105.63104.50-271,719-1.57%
2025/03/2127107.5400.00106.50271,7141.57%
2025/03/1300.001.7105.56103.50-1.71,707-0.10%
2025/03/1200.001.3107.15107.00-1.31,695-0.08%
2025/03/1100.001.3106.12107.00-1.31,697-0.08%
2025/03/102105.002.3106.59107.00-0.31,686-0.02%
2025/03/072.6107.961.8107.61107.500.81,6650.05%
2025/03/053114.5000.00115.5031,6450.18%
2025/03/0400.000.1112.00114.50-0.11,634-0.01%
2025/03/031114.001.3113.58112.50-0.31,620-0.02%
2025/02/271.2113.7800.00109.001.21,5680.07%
2025/02/262116.0000.00115.5021,5530.13%
2025/02/2500.000.2112.00113.00-0.21,443-0.01%
2025/02/2400.000.2113.50115.00-0.21,431-0.01%
2025/02/2100.000.5112.70113.00-0.51,412-0.04%
2025/02/2000.001.3110.40110.00-1.31,389-0.09%
2025/02/1900.000.8109.73110.00-0.81,396-0.05%
2025/02/181.2109.252109.00110.00-0.81,401-0.06%
2025/02/170.1112.9900.00112.500.11,3970.01%
2025/02/1300.000.4111.00111.50-0.41,413-0.02%
2025/02/123111.003109.56112.0001,4080.00%
2025/02/114.8113.653.3111.07109.001.51,3920.11%
2025/02/102.2117.953118.27118.50-0.81,337-0.06%
2025/02/072.2119.180.4119.00120.501.91,3510.14%
2025/02/062.3119.566119.17119.00-3.81,329-0.28%
2025/02/0400.00199.80103.00-11,201-0.08%
2025/01/15294.5000.0093.1021,3800.14%
2025/01/14195.7000.0096.1011,3720.07%
2025/01/0300.00196.3098.30-11,240-0.08%
2024/12/2700.00392.3092.00-31,223-0.25%
2024/12/12189.8000.0090.2011,1990.08%
2024/11/2900.00198.2097.50-11,136-0.09%
2024/11/28193.6000.0092.4011,1100.09%
2024/11/051107.003108.17106.00-2782-0.26%
2024/11/013109.672108.00105.0017300.14%
2024/10/2100.00587.0086.70-5418-1.19%
2024/10/1800.00187.4086.80-1450-0.22%
2024/10/1700.00188.6088.30-1469-0.21%
2024/10/0900.001.590.1089.50-1.5508-0.30%
2024/10/08291.7000.0091.1025070.39%
2024/10/0700.00188.7088.80-1506-0.20%
2024/09/2600.00287.2086.60-2576-0.35%
2024/08/160.184.6000.0084.600.17430.02%
2024/08/120.384.2000.0084.900.37800.04%
2024/08/0800.00185.8085.40-1799-0.13%
2024/08/06179.7000.0080.8017830.13%
2024/08/050.183.6000.0083.000.17640.01%
2024/08/02392.53291.9092.2017410.13%
2024/08/01293.8000.0094.5027360.27%
2024/07/18298.6000.0099.4026760.30%
2024/07/11195.3000.0095.2016500.15%
2024/07/10297.20196.8096.6016580.15%
2024/07/0800.001101.00100.50-1655-0.15%
2024/07/03298.0000.0096.7026280.32%
2024/07/0100.001100.00101.00-1610-0.16%
2024/06/27297.2000.0095.7025820.34%
2024/06/26197.10198.1097.6005760.00%
2024/06/25192.5000.0094.3015680.18%
2024/06/2100.00294.0093.70-2607-0.33%
2024/06/20194.5000.0094.5016350.16%
2024/06/1300.000.196.6096.90-0.1651-0.02%
2024/06/12194.0000.0094.8016380.16%
2024/05/230.194.1000.0093.600.18420.01%
2024/04/1700.00193.7092.60-11,541-0.06%
2024/04/01299.901100.0099.6011,8050.06%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章